Evidence map›Paper›PMID 25101794›Full record

ArticlePLoS pathogens2014

The Vi capsular polysaccharide enables Salmonella enterica serovar typhi to evade microbe-guided neutrophil chemotaxis.

Tamding Wangdi, Cheng-Yuk Lee, Alanna M Spees, Chenzhou Yu, Dawn D Kingsbury, Sebastian E Winter, Christine J Hastey, R Paul Wilson, Volkmar Heinrich, Andreas J Bäumler

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
11.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 74 citations in OpenAlex.

  1. IgA and IgG1 Specific to Vi Polysaccharide ofFrontiers in immunology · 2019
    Trial
  2. Microorganisms · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. FromACS omega · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Science immunology · 2021
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Tamding WangdiDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, California, United States of America.
Cheng-Yuk LeeDepartment of Biomedical Engineering, University of California, Davis, Davis, California, United States of America.
Alanna M SpeesDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, California, United States of America.
Chenzhou YuDepartment of Biomedical Engineering, University of California, Davis, Davis, California, United States of America.
Dawn D KingsburyDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, California, United States of America.
Sebastian E WinterDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, California, United States of America.
Christine J HasteyDepartment of Biomedical Engineering, University of California, Davis, Davis, California, United States of America.
R Paul WilsonDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, California, United States of America.
Volkmar HeinrichDepartment of Biomedical Engineering, University of California, Davis, Davis, California, United States of America.
Andreas J BäumlerDepartment of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, California, United States of America.
University of California, Davis · US

Funding

Virulence Factors of SalmonellaR01AI044170 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI BAUMLER, ANDREAS J · 1999 to 2022
$8.5M
Comparative Medical Science Training ProgramT32OD011147 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI JEROEN SAEIJ, Sara Michelle Thomasy · 2012 to 2026
$5.5M
Salmonella Host interactionsR37AI044170 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Andreas J Baumler, Renee M Tsolis · 2025 to 2026
$1.2M
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR012088 · NCRR · UNIVERSITY OF CALIFORNIA DAVIS · PI CURRY, FITZ-ROY E · 1996 to 1996
–
NCRR NIH HHS C06 RR012088NCRR NIH HHS C06-RR12088-01NIAID NIH HHS AI044170NIAID NIH HHS R01 AI044170NIAID NIH HHS R37 AI044170NIH HHS T32 OD011147
6 · The paper itself

Abstract

Salmonella enterica serovar Typhi (S. Typhi) causes typhoid fever, a disseminated infection, while the closely related pathogen S. enterica serovar Typhimurium (S. Typhimurium) is associated with a localized gastroenteritis in humans. Here we investigated whether both pathogens differ in the chemotactic response they induce in neutrophils using a single-cell experimental approach. Surprisingly, neutrophils extended chemotactic pseudopodia toward Escherichia coli and S. Typhimurium, but not toward S. Typhi. Bacterial-guided chemotaxis was dependent on the presence of complement component 5a (C5a) and C5a receptor (C5aR). Deletion of S. Typhi capsule biosynthesis genes markedly enhanced the chemotactic response of neutrophils in vitro. Furthermore, deletion of capsule biosynthesis genes heightened the association of S. Typhi with neutrophils in vivo through a C5aR-dependent mechanism. Collectively, these data suggest that expression of the virulence-associated (Vi) capsular polysaccharide of S. Typhi obstructs bacterial-guided neutrophil chemotaxis.

Indexed as

AnimalsChemotaxis, LeukocyteComplement C5aEnzyme-Linked Immunosorbent AssayFemaleFlow CytometryHumansMiceNeutrophil InfiltrationPolysaccharides, BacterialReceptor, Anaphylatoxin C5aSalmonella typhiSalmonella typhimuriumTyphoid Fevercapsular polysaccharide, SalmonellaComplement C5aPolysaccharides, BacterialReceptor, Anaphylatoxin C5a

Identifiers

PMID25101794
PMCPMC4125291
OpenAlexW2132030430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.